Parkinson's disease (PD) is a progressive and chronic neurodegenerative disorder,
characterized by progressive loss of dopaminergic neurons in substantia nigra. The etiology …

Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors and they serve to
be a promising therapeutic target for several neurodegenerative disorders, which includes …

Over 25 years have passed since peroxisome proliferators‐activated receptors (PPARs),
were first described. Like other members of the nuclear receptors superfamily, PPARs have …

Parkinson's disease (PD) is amongst the most frequent neurodegenerative disorders, the
main pathologic hallmark of which is the degeneration of the substantia nigra pars …

Evidence suggests inflammation, mitochondria dysfunction, and oxidative stress play major
roles in Parkinson's disease (PD), where the primary pathology is the significant loss of …

One of the utmost frequently emerging neurodegenerative diseases, Parkinson's disease
(PD) must be comprehended through the forfeit of dopamine (DA)-generating nerve cells in …

There is increasing evidence for the involvement of mitochondrial dysfunction and oxidative
stress in the pathogenesis of many of the major neurodegenerative and neuroinflammatory …

As the growth of the aging population continues to accelerate globally, increased
prevalence of neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's …

Peroxisome proliferator-activated receptor gamma (PPARgamma) has already been
considered as an attractive therapeutic target for the treatment of metabolic disorders …

The peroxisome proliferator-activated receptor gamma (PPARγ) is a ligand-activated
transcriptional factor that belongs to the nuclear hormone receptor superfamily. PPARγ was …